Viewing Study NCT06702995

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:27 PM
Ignite Modification Date: 2026-02-01 @ 8:08 PM
Study NCT ID: NCT06702995
Status: RECRUITING
Last Update Posted: 2025-04-20
First Post: 2024-11-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Evopoint Biosciences Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castrate-Resistant Prostate Cancer View
None mCRPC (Metastatic Castration-resistant Prostate Cancer) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None XNW5004 View
None Enzalutamide View